|4Feb 13, 4:13 PM ET

Cook Meredith 4

4 · ANI PHARMACEUTICALS INC · Filed Feb 13, 2026

Research Summary

AI-generated summary of this filing

Updated

ANI Pharmaceuticals (ANIP) Meredith Cook Sells 3,011 Shares

What Happened
Meredith Cook, Senior Vice President, General Counsel & Secretary of ANI Pharmaceuticals (ANIP), had 3,011 shares withheld to satisfy tax withholding related to the vesting of performance stock units. The shares were valued at $76.25 each, for a total of $229,589. This was a tax-withholding disposition (not an open-market sale or purchase).

Key Details

  • Transaction date: 2026-02-11; Price: $76.25 per share; Total value: $229,589.
  • Transaction type/code: F — shares withheld for tax purposes (disposition).
  • Footnote: Withholding relates to the vesting of 8,104 performance stock units originally granted April 6, 2023; withholding exemption cited under Rule 16b-3.
  • Shares owned after the transaction: not specified in the provided filing excerpt.
  • Filing: Report filed Feb 13, 2026 for a Feb 11, 2026 transaction — appears timely under the two-business-day Form 4 requirement.

Context
Tax-withholding dispositions are routine when equity awards vest; shares are retained by the company (or sold on the insider’s behalf) to cover required taxes and do not necessarily reflect the insider’s view of the stock. Rule 16b-3 provides an exemption for certain transactions in connection with compensation plans; this filing indicates that exemption was relied upon for the withholding.

Insider Transaction Report

Form 4
Period: 2026-02-11
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Transactions
  • Tax Payment

    Common Stock

    [F1]
    2026-02-11$76.25/sh3,011$229,58971,363 total
Footnotes (1)
  • [F1]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 8,104 performance stock units, the grant of which was previously reported on April 6, 2023.
Signature
/s/ Meredith W. Cook|2026-02-13

Documents

1 file
  • 4
    wk-form4_1771017195.xmlPrimary

    FORM 4